
|Articles|March 11, 2019
Envigo launches PATHWAY
Advertisement
Envigo, a provider of non-clinical contract research services and research models, announced PATHWAY-an integrated solution for non-clinical safety assessment programs to enable first-in-human clinical trials. It is meant to manage the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
4
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
5






.png)



.png)



.png)
.png)
